Neeltje A. Kootstra - Concepedia

Author

Neeltje A. Kootstra

Also Known As

A el Berkaoui, F W N M Wit, Ineke Stolte, Jan M Prins, Jan M. Prins, Kootstra, Neeltje A., L.A. van Vught, N A Kootstra, N KOOTSTRA, N Kootstra

344

Publications

15.7K

Citations

H-Index

114

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Amsterdam University Medical Centers Sanquin GGD Amsterdam

About

Neeltje A. Kootstra is an author at University of Amsterdam specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	61	6.1K
2	Public Health	5	5	241
3	Natural Sciences	3	3	825
4	Engineering	1	1	107
5	Health Sciences	1	1	62

Neeltje A. Kootstra

170

Publications

13.6K

Citations

H-Index

Page 1

	Year	Citations
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten, Science	2020	1.3K
Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population Hanneke Schuitemaker, M. Koot, Neeltje A. Kootstra, Journal of Virology Primary ImmunodeficiencyBiological PhenotypeHiv-1 PopulationsHuman RetrovirusImmunology	1992	1K
Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule Ron A. M. Fouchier, M Groenink, Neeltje A. Kootstra, Journal of Virology Viral ReplicationImmunologyMolecular BiologyChemical BiologyHuman Retrovirus	1992	768
Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study J. Schouten, Ferdinand W.N.M. Wit, Ineke G. Stolte, Clinical Infectious Diseases	2014	759
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. Angélique B. van ’t Wout, Neeltje A. Kootstra, G A Mulder-Kampinga, Journal of Clinical Investigation Primary ImmunodeficiencyHuman RetrovirusPathogenesisImmunologyAntiviral Response	1994	490
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences Fernando O. Martínez, Laura Helming, Ronny Milde, Blood	2013	482
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity Mads Delbo Larsen, Erik L. de Graaf, Myrthe E. Sonneveld, Science Humoral ResponseViral PathogenesisImmunologyImmunodominanceViral Responses	2020	396
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture Hanneke Schuitemaker, Neeltje A. Kootstra, R E de Goede, Journal of Virology T-regulatory CellImmunologyPathologyHiv-1 IsolatesImmunotherapy	1991	325
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial Meike H. van der Ree, J. Marleen de Vree, F. Stelma, The Lancet Phase 1BHepatologyHepatitis CViral HepatitisAntiviral Therapy	2017	259
Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting <i>in vivo</i> Alexander Pfeifer, Eugene P. Brandon, Neeltje A. Kootstra, Proceedings of the National Academy of Sciences	2001	225

Page 1